tradingkey.logo

Vsee Health Inc

VSEE
0.352USD
-0.015-4.19%
Close 02/06, 16:00ETQuotes delayed by 15 min
5.99MMarket Cap
0.77P/E TTM

Vsee Health Inc

0.352
-0.015-4.19%

More Details of Vsee Health Inc Company

VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.

Vsee Health Inc Info

Ticker SymbolVSEE
Company nameVsee Health Inc
IPO dateNov 04, 2021
CEOAisiku (Imoigele)
Number of employees154
Security typeOrdinary Share
Fiscal year-endNov 04
Address980 N Federal Hwy
CityBOCA RATON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33432
Phone15616727068
Websitehttps://vsee.com/
Ticker SymbolVSEE
IPO dateNov 04, 2021
CEOAisiku (Imoigele)

Company Executives of Vsee Health Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Imoigele Aisiku, M.D.
Dr. Imoigele Aisiku, M.D.
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
3.26M
--
Dr. Milton Chen, Ph.D.
Dr. Milton Chen, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.87M
--
Mr. Jerry Leonard
Mr. Jerry Leonard
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
560.72K
--
Dr. Scott Metzger
Dr. Scott Metzger
Independent Director
Independent Director
77.25K
+68624.00%
Mr. Kevin Lowdermilk
Mr. Kevin Lowdermilk
Independent Director
Independent Director
68.62K
--
Mr. Colin O'Sullivan
Mr. Colin O'Sullivan
Independent Director
Independent Director
--
--
Ms. Cydonii V. Fairfax
Ms. Cydonii V. Fairfax
Independent Director
Independent Director
--
--
Mr. David L. Wickersham
Mr. David L. Wickersham
Independent Director
Independent Director
--
--
Mr. Dave Gentry
Mr. Dave Gentry
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Imoigele Aisiku, M.D.
Dr. Imoigele Aisiku, M.D.
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
3.26M
--
Dr. Milton Chen, Ph.D.
Dr. Milton Chen, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.87M
--
Mr. Jerry Leonard
Mr. Jerry Leonard
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
560.72K
--
Dr. Scott Metzger
Dr. Scott Metzger
Independent Director
Independent Director
77.25K
+68624.00%
Mr. Kevin Lowdermilk
Mr. Kevin Lowdermilk
Independent Director
Independent Director
68.62K
--
Mr. Colin O'Sullivan
Mr. Colin O'Sullivan
Independent Director
Independent Director
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
8.91%
Aisiku (Imoigele)
8.09%
Chen (Milton)
7.13%
Homrich Berg
1.50%
Leonard (Jerry)
1.39%
Other
72.97%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
8.91%
Aisiku (Imoigele)
8.09%
Chen (Milton)
7.13%
Homrich Berg
1.50%
Leonard (Jerry)
1.39%
Other
72.97%
Shareholder Types
Shareholders
Proportion
Individual Investor
18.03%
Hedge Fund
8.94%
Investment Advisor/Hedge Fund
2.99%
Investment Advisor
0.31%
Venture Capital
0.05%
Other
69.68%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
23
1.36M
3.45%
-22.08K
2025Q3
25
1.34M
7.90%
+98.13K
2025Q2
31
9.92M
63.30%
-1.88M
2025Q1
31
10.50M
67.03%
-685.58K
2024Q4
28
9.85M
62.87%
-1.21M
2024Q3
61
10.11M
73.63%
-10.21M
2024Q2
59
10.44M
76.15%
-2.85M
2024Q1
65
3.46M
96.42%
-12.49M
2023Q4
66
3.44M
82.48%
-12.61M
2023Q3
66
4.08M
97.64%
-11.96M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Aisiku (Imoigele)
3.26M
8.26%
--
--
Dec 19, 2025
Chen (Milton)
2.87M
7.28%
+28.70K
+1.01%
Dec 19, 2025
Homrich Berg
602.65K
1.53%
+602.65K
--
Sep 30, 2025
SCS Capital Management LLC
502.50K
1.27%
+2.50K
+0.50%
Nov 06, 2025
Wickersham (David L.)
214.00K
0.54%
--
--
Dec 19, 2025
Geode Capital Management, L.L.C.
79.44K
0.2%
+1.33K
+1.71%
Sep 30, 2025
Metzger (Scott)
8.63K
0.02%
--
--
Dec 19, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI